The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Regulatory News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.05
Bid: 4.00
Ask: 4.10
Change: 0.60 (17.39%)
Spread: 0.10 (2.50%)
Open: 3.50
High: 4.75
Low: 4.05
Prev. Close: 3.45
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Aug 2023 17:29

RNS Number : 9825J
Polarean Imaging PLC
21 August 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00Bf3DT583

Issuer Name

POLAREAN IMAGING PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

NUKEM Isotopes GmbH

City of registered office (if applicable)

Alzenau

Country of registered office (if applicable)

Germany

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

16-Aug-2023

6. Date on which Issuer notified

17-Aug-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

6.057000

0.000000

6.057000

13073462

Position of previous notification (if applicable)

5.525000

5.525000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BF3DT583

11523462

1550000

5.339000

0.718000

Sub Total 8.A

13073462

6.057000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

21-Aug-2023

13. Place Of Completion

Alzenau, Germany

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUAUNROOUWUAR
Date   Source Headline
1st Feb 20234:25 pmRNSFDA grants New Chemical Entity designation
27th Jan 20237:00 amRNSBlock listing six monthly return
28th Dec 20229:05 amRNSSecond Price Monitoring Extn
28th Dec 20229:00 amRNSPrice Monitoring Extension
28th Dec 20227:00 amRNSFDA Approves XENOVIEW™ (Xe 129 hyperpolarized)
3rd Oct 202211:05 amRNSSecond Price Monitoring Extn
3rd Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSUpdate on New Drug Application
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 202211:06 amRNSSecond Price Monitoring Extn
22nd Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20229:05 amRNSSecond Price Monitoring Extn
22nd Sep 20229:00 amRNSPrice Monitoring Extension
22nd Sep 20227:04 amRNSUpdate on New Drug Application
31st Aug 20227:00 amRNSHalf-year Report
26th Aug 20227:00 amRNSDirectorate appointment
4th Aug 20224:40 pmRNSSecond Price Monitoring Extn
4th Aug 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSTotal voting rights and block listing return
8th Jul 20227:00 amRNSSystem delivery
29th Jun 20224:35 pmRNSResult of AGM
18th May 20227:00 amRNSFinal Results
11th May 20227:00 amRNSNotice of Results
11th May 20227:00 amRNSOxford research collaboration in long COVID
5th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
25th Apr 20227:00 amRNSNew system order
20th Apr 20227:00 amRNSNew Drug Application Resubmission update
14th Apr 20227:00 amRNSAppointment of Non-Executive Director
8th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20222:05 pmRNSSecond Price Monitoring Extn
31st Mar 20222:00 pmRNSPrice Monitoring Extension
31st Mar 202211:06 amRNSSecond Price Monitoring Extn
31st Mar 202211:00 amRNSPrice Monitoring Extension
31st Mar 20229:00 amRNSPrice Monitoring Extension
31st Mar 20227:00 amRNSNew Drug Application Resubmission
25th Feb 20227:00 amRNSTotal Voting Rights
14th Feb 20227:00 amRNSNew system order
28th Jan 20227:01 amRNSBlock Listing Return
28th Jan 20227:00 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSTotal Voting Rights
26th Oct 20214:41 pmRNSSecond Price Monitoring Extn
26th Oct 20214:36 pmRNSPrice Monitoring Extension
26th Oct 20212:05 pmRNSSecond Price Monitoring Extn
26th Oct 20212:00 pmRNSPrice Monitoring Extension
12th Oct 20214:41 pmRNSSecond Price Monitoring Extn
12th Oct 20214:35 pmRNSPrice Monitoring Extension
12th Oct 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.